Assignee
ATAI THERAPEUTICS INC
US·11 granted patents·11 pending applications·20 citations·filing 2022–2025
Top patents by PatentIndex Score
22 records- 0196US12472163B2Compositions of matter and pharmaceutical compositionsATAI THERAPEUTICS INC·Filed 2025·Granted Nov 18, 2025·1 cites·22 claims
- 0296US12065405B2Prodrugs and conjugates of dimethyltryptamineATAI THERAPEUTICS INC·Filed 2023·Granted Aug 20, 2024·4 cites·30 claims
- 0394US12396982B2Compositions of matter and pharmaceutical compositionsATAI THERAPEUTICS INC·Filed 2024·Granted Aug 26, 2025·2 cites·20 claims
- 0494US12012381B2Dimethyltryptamine analogues as nitric oxide delivery drugsATAI THERAPEUTICS INC·Filed 2022·Granted Jun 18, 2024·4 cites·33 claims
- 0591US12016866B2Methods and compositions for potentiating the action of opioid analgesics using iboga alkaloidsATAI THERAPEUTICS INC·Filed 2022·Granted Jun 25, 2024·2 cites·20 claims
- 0688US12128027B2N—N-dimethyltryptamine (DMT) and DMT analog compositions, methods of making, and methods of use thereofATAI THERAPEUTICS INC·Filed 2023·Granted Oct 29, 2024·4 cites·20 claims
- 0785US12378194B2N, n-dimethyltryptamine salts and crystalline salt formsATAI THERAPEUTICS INC·Filed 2022·Granted Aug 5, 2025·2 cites·16 claims
- 0884US12351537B2Dimethoxyphenylalkylamine activators of serotonin receptorsATAI THERAPEUTICS INC·Filed 2024·Granted Jul 8, 2025·0 cites·11 claims
- 0982US2024325407A1Methods and compositions for potentiating the action of opioid analgesics using iboga alkaloidsATAI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1080US12344570B2Aminotetraline activators of serotonin receptorsATAI THERAPEUTICS INC·Filed 2023·Granted Jul 1, 2025·0 cites·18 claims
- 1179US2025282712A1Dimethoxyphenylalkylamine activators of serotonin receptorsATAI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1277US12097332B2Systems, devices, and methods for generating and manipulating objects in a virtual reality or multi-sensory environment to maintain a positive state of a userATAI THERAPEUTICS INC·Filed 2023·Granted Sep 24, 2024·1 cites·20 claims
- 1375US2025282708A1Aminotetraline activators of serotonin receptorsATAI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1471US2025388538A1N,n-dimethyltryptamine salts and crystalline salt formsATAI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1567US2024287107A1Prodrugs of dimethyltryptamine and derivatives thereofATAI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1667US2025197395A1Ibogaine and noribogaine analogs and uses thereofATAI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1766US12343319B2Compositions and methods for treatment of diseases and disordersATAI THERAPEUTICS INC·Filed 2024·Granted Jul 1, 2025·0 cites·13 claims
- 1866US2024366542A1Sulfoximine activators of serotonin receptorsATAI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1965US2024376116A1Ibogaine and noribogaine analogs and methods of useATAI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2058US2024199544A1Crystalline forms of n,n-dimethyltryptamine and methods of using the sameATAI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2158US2025268846A1Compositions and methods for treatment of diseases and disordersATAI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2246US2026027082A1Methods for treating treatment resistant depressionATAI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ATAI THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →